LCN2 expression inhibits proliferation, invasion and metastasis, with the ability to reverse the epithelial to mesenchymal transition process, suggesting LCN2 as a potential metastasis suppressor and a therapeutic target against HCC [19]. The gene discussed is LCN2; the disease is hepatocellular carcinoma.